Peptides run the gamut — from FDA-approved GLP-1s to compounds barely studied in humans. Wherever yours falls, track it against the outcomes you actually care about, watch your own response over time, and help build the evidence base for one of the fastest-growing frontiers in health.
You're on the list.
We'll email you the moment early access opens.
Even where the clinical data exists, it can't tell you how a peptide plays out for you — and for many peptides, that data barely exists at all. No one's been collecting real-world results in a consistent, verifiable way. N-of-1 changes that from both ends.
Log what you're taking — any peptide, any protocol — and track the outcomes you care about, so "is this doing anything?" becomes real evidence instead of a guess.
Your de-identified results feed a shared evidence base — turning thousands of scattered anecdotes into something the field can actually learn from.
The bigger that shared base grows, the more your own tracking can tell you. Everyone's data makes each person's picture sharper.
Tell us what you're taking. That's it for now.
Whatever peptide(s), dose, and timing you're on. Takes seconds.
Short, structured check-ins on recovery, sleep, energy — so you see your trend, not just vibes.
Your de-identified results join the shared pool that makes everyone's tracking sharper — including yours.
N-of-1 Health was founded by a PhD neuroscientist who first built it for herself — a way to bring the rigor of real study design to her own health decisions, instead of running on guesswork. It's backed by a team of clinical, medical, and regulatory advisors. Any research use of contributed data is designed to run under independent ethics (IRB) oversight, with clear consent — because credible data is the entire point.
You're on the list.
We'll email you the moment early access opens.